Research
Education
Healthcare
Community
About
Jul 01, 2026 | ProBio Inc.
ProBio's AAV Manufacturing Excellence Powers UC Irvine and GlyTR Therapeutics First‑in‑Class Pan-Cancer CAR‑T Program
UC Irvine researchers and GlyTR Therapeutics have advanced a groundbreaking, first-in-class pan-cancer CAR-T platform with the potential to expand the reach of cell therapy into solid tumors.
Jun 23, 2026 | UC Irvine School of Medicine
Researchers Develop a Potential Blood Test for Diagnosing ALS
UC Irvine researchers are part of an international team developing a new blood test to diagnose ALS and track its progression.
Jun 18, 2026 | UC Irvine School of Medicine
CBD to Alleviate ‘Chemo Brain’ in Cancer Survivors
A new study by UC Irvine researchers suggests that CBD can help treat “brain fog” for people with cancer-therapy-related cognitive impairments (CRCI), addressing an unmet medical need.
Matt Miller Director mrmille2@uci.edu
Michelle Heath Manager mstrombe@hs.uci.edu
Shani Murray Senior Science Writer shanim@hs.uci.edu
Communications & PR Office
Stay Connected
The groundbreaking volume Perspectives on the Human Genome Project and Genomics takes a look back at one of the greatest scientific feats in history, offering a roadmap for realizing the potential of precision medicine.
Women are now substantially represented in clinical trials for FDA-approved drugs, according to a new study led by Sophie Zaaijer, PhD. Yet gaps persist, signaling there’s more to be done in making medicine truly equitable.
A new UC Irvine-led study finds overlooked form of adversity can reveal hidden mental health risks in nearly 30,000 children.
Jul 22, 2026 | Medical Xpress
Study Shows Progress in Women's Inclusion in Clinical Trials
A new study provides encouraging evidence that most clinical trials have substantial female representation relative to disease burden. "These results show promise—the field has moved beyond widespread exclusion," says Sophie Zaaijer, PhD, who led the study as a research specialist in the Division of Hematology and Oncology at the UC Irvine School of Medicine.
Jul 22, 2026 | The Observer
What Black Men Need to Know About Low Testosterone
To help readers understand the condition beyond the headlines, The OBSERVER spoke with Dr. Melvin L. Seard II, a board-certified UCI Health urologist, associate clinical professor of urology at the UC Irvine School of Medicine, director of ambulatory urologic services, and a longtime advocate for patient education.